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Abstract Glucose-6-phosphate dehydrogenase (G6PD) plays an
important role in cellular redox homeostasis, which is crucial for
cell survival. In the present study, we found that G6PD status
determines the response of cells exposed to nitric oxide (NO)
donor. Treatment with NO donor, sodium nitroprusside (SNP),
caused apoptosis in G6PD-deficient human foreskin fibroblasts
(HFF1), whereas it was growth stimulatory in the normal
counterpart (HFF3). Such effects were abolished by NO
scavengers like hemoglobin. Ectopic expression of G6PD in
HFF1 cells switched the cellular response to NO from apoptosis
to growth stimulation. Experiments with 1H-[1,2,4]oxadiazolo-
[4,3-a]quinoxalin-1-one and 8-bromo-cGMP showed that the
effects of NO on HFF1 and HFF3 cells were independent of
cGMP signalling pathway. Intriguingly, trolox prevented the
SNP-induced apoptosis in HFF1 cells. These data demonstrate
that G6PD plays a critical role in regulation of cell growth and
survival. ß 2000 Federation of European Biochemical Socie-
ties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The major function of glucose-6-phosphate dehydrogenase
(G6PD) is to generate reducing equivalents in the form of
NADPH to meet the cellular needs for reductive biosynthesis
and maintenance of cellular redox homeostasis. The impor-
tance of G6PD is highlighted by clinical manifestation of its
de¢ciency. G6PD de¢ciency, a common enzymopathy a¡ect-
ing over 200 million people worldwide, can cause neonatal
jaundice, drug- or infection-induced hemolytic crisis, favism
and, less commonly, non-spherocytic hemolytic anemia [1^3].
Until recently, most advances in the ¢eld have been made on
the pathophysiology of G6PD-de¢cient erythrocytes and the
molecular characterization of di¡erent G6PD variants. The
chronic e¡ects of G6PD de¢ciency on cells other than eryth-
rocytes remain largely unexplored.
Several recent studies have shown that G6PD de¢ciency
does a¡ect the physiology of nucleated cells [4^7]. For in-
stance, a number of G6PD-de¢cient ¢broblasts grow at a
reduced rate compared to the normal control [5]. Reduction
in growth rate of these cells implies diminished cellular re-
sponses to mitogens. It is speculative that G6PD de¢ciency
may alter cellular responses to growth factors and other sig-
nalling molecules. In the present study, nitric oxide (NO) has
been found to exert di¡erent biological e¡ects on normal and
G6PD-de¢cient cells.
2. Materials and methods
2.1. Cell culture
The G6PD-de¢cient human foreskin ¢broblast, designated HFF1,
and its normal counterpart, designated HFF3, were isolated and
maintained as previously described [5]. LGIN and LKGIN cells,
which expressed G6PD from an exogenous human G6PD gene,
were generated from HFF1 cells by transduction with G6PD-encoding
retroviral vectors as described [5]. LEIN cells, which expressed en-
hanced green £uorescent protein (EGFP), served as control. These
cells were cultured in Dulbecco’s modi¢ed Eagle medium (Gibco
Life Technology, Gaithersburg, MD, USA) supplemented with 10%
fetal calf serum, 100 U/ml of penicillin, 100 U/ml of streptomycin and
0.25 mg/ml of amphotericin at 37‡C in a humidi¢ed atmosphere con-
taining 5% CO2. The cell number was determined by the trypan blue
dye exclusion method.
For cultures receiving NO treatment, about 2U105 cells were
seeded on day 31 (i.e. 24 h before drug treatment), and treated
with indicated concentrations of sodium nitroprusside (SNP; Calbio-
chem, San Diego, CA, USA) on day 0. The cell number and the extent
of apoptosis were quanti¢ed on subsequent days. For delineation of
NO signalling pathway, cells were pre-treated with selective inhibitor
of NO-sensitive guanylyl cyclase, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxa-
lin-1-one (ODQ; Calbiochem, San Diego, CA, USA) for 30 min be-
fore SNP addition, or incubated alone with 8-bromo-guanosine 3P,5P-
cyclic monophosphate (cGMP) (Calbiochem, San Diego, CA, USA).
For studies with trolox, cells were treated with 200 WM of trolox
(Calbiochem, San Diego, CA, USA) for 30 min prior to addition of
SNP.
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2.2. Flow cytometric analysis and terminal dUTP nick end labelling
(TUNEL) of apoptotic cells
Cells were rinsed with ice-cold phosphate-bu¡ered saline (PBS),
trypsinized and resuspended in 0.3 ml of PBS. They were then ¢xed
and permeabilized by addition of 0.7 ml of ethanol. After a brief
wash, the cells were gently resuspended in 1 ml of propidium iodide
(PI) stain solution (40 Wg/ml PI (Sigma, St. Louis, MO, USA), 100 Wg/
ml RNase A and 0.5% Triton X-100 in PBS), and incubated at room
temperature for 30 min before analysis on a FACSCAN £ow cytom-
eter (Becton Dickinson, CA, USA). The sub-G1 fraction is considered
as the apoptotic cells and taken as a measure of the extent of apop-
tosis [8]. The sub-G1 phase was quanti¢ed using Mod¢t software
(Becton Dickinson, CA, USA). TUNEL was performed with in situ
cell death detection kit (Roche, Germany), according to the instruc-
tions of the manufacturer. Finally, the samples were analyzed by £ow
cytometry, and the TUNEL-positive fraction was quanti¢ed by
CELLQuest software (Becton Dickinson, CA, USA).
3. Results
3.1. Exogenous NO donor evoked di¡erent responses in normal
and G6PD-de¢cient human ¢broblasts
The HFF1 cells were isolated from foreskin of G6PD-de¢-
cient neonate, who had been identi¢ed to carry the Taiwan-
Hakka variant (G6PD1376T). The control HFF3 cells were
derived from foreskin of normal, sex- and age-matched infant.
The GCT transversion caused a signi¢cant reduction in
G6PD activity in HFF1 cells (0.11 þ 0.005 U/mg of cell lysate)
as compared with that of HFF3 cells (0.3 þ 0.01 U/mg of cell
lysate) [5]. Upon exposure to NO donor SNP, HFF1 and
HFF3 cells showed entirely di¡erent growth patterns. Addi-
tion of 50 or 100 WM of SNP enhanced growth of HFF3 cells
as compared to the control (Fig. 1A). Such an e¡ect became
prominent on day 5 (i.e.V120 h after SNP addition), but was
less conspicuous as the cultures reached con£uence on day 7.
At concentrations ranging from 10 to 50 WM, the growth
stimulatory e¡ect of NO donor displayed dose-dependence
(Fig. 1C). The number of HFF3 cells (counted on day 5 after
SNP addition) increased from (44.16 þ 1.45)U105 (at 10 WM)
to (60.4 þ 1.98)U105 (at 50 WM). On the contrary, as com-
pared to that of untreated control, the number of SNP-treated
HFF1 cells decreased progressively with time (Fig. 1B). Such
reduction in cell number showed dose-dependence (Fig. 1C),
and was due to an increased rate of cell death.
3.2. The cell death induced in HFF1 cells by SNP was typical
of apoptosis
SNP induced apoptosis in HFF1 cells, which exhibited con-
voluted outline and characteristic membrane blebbings (un-
published observation). The extent of apoptosis was quanti-
¢ed by two approaches. First, the appearance of cells with a
low DNA stainability (sub-G1 fraction) in cell population has
been considered as a marker of apoptosis [8]. As evident in
Fig. 2B, the extent of apoptosis in HFF1 cells signi¢cantly
increased on day 3 after SNP addition. Treatment with
50 and 100 WM of SNP for 7 days resulted in about 35.12 þ
4.12% and 53.06 þ 5.07% of apoptosis, respectively. Beginning
with the SNP concentration of 10 WM, the degree of apoptosis
increased signi¢cantly with concentration (Fig. 2C). In con-
trast, SNP did not induce apoptosis in HFF3 cells at any SNP
concentration from 10 to 100 WM (Fig. 2A,C).
TUNEL labelling of the free DNA ends formed by frag-
mentation of genomic DNA, followed by £ow cytometric
analysis, gives another reliable means for quanti¢cation of
apoptosis [9]. Incubation of HFF1 cells SNP caused an in-
crease in mean relative £uorescence, indicating incorporation
of £uorescein-dUTP onto ends of nuclear DNA fragments in
apoptotic cells (Fig. 3A). This was supported by £uorescence
microscopic examination of TUNEL-labelled, SNP-treated
Fig. 1. E¡ects of SNP on growth kinetics of normal (HFF3) and G6PD-de¢cient (HFF1) human foreskin ¢broblasts. Twenty-four hours before
SNP addition (i.e. day 31), about 2U105 HFF3 (A) or HFF1 (B) cells were seeded, and treated with 0, 50 and 100 WM of SNP on day 0.
Cell number was determined at daily intervals. (C) E¡ects of SNP on HFF3 and HFF1 cells showed dose-dependence. About 2U105 HFF3 or
HFF1 cells were treated with indicated concentrations of SNP, and the cell number was determined 5 days after treatment. Results are ex-
pressed as mean þ S.E.M. of ¢ve determinations.
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HFF1 cells (data not shown). Addition of SNP to HFF1 cells
caused a signi¢cant increase in the percentage of TUNEL-
positive cells in a dose-dependent manner (Fig. 3B). Mean-
while, an insigni¢cant level of apoptosis was detected in SNP-
treated HFF3 cells.
3.3. The observed e¡ects of SNP are most likely to be mediated
by NO
When HFF3 cells were co-incubated with 50 WM of SNP
and 50 WM of hemoglobin or freshly prepared erythrocytes,
both of which are well known NO scavengers, the growth
stimulatory e¡ect of SNP was completely inhibited (data not
shown). Similarly, treatment with hemoglobin or freshly pre-
pared erythrocytes rescued HFF1 cells from SNP-induced
apoptosis (data not shown). Furthermore, potassium ferro-
cyanide (K4Fe(CN)6) or potassium ferricyanide (K3Fe(CN)6),
the analogues of SNP but devoid of NO, did not mimic the
e¡ects of SNP at concentrations ranging from 10 WM to
C
Fig. 3. Quanti¢cation of the extent of apoptosis in HFF1 and
HFF3 cells by TUNEL assay. (A) HFF3 and HFF1 cells were
treated with varying concentrations of SNP, and the level of apop-
tosis was determined 5 days after treatment by TUNEL assay and
£ow cytometric analysis. Representative histograms of HFF1 cells
treated with 0, 25 and 100 WM of SNP are shown here. (B) The ex-
tent of apoptosis with varying SNP concentrations for HFF1 and
HFF3 cells is shown here. Results are expressed as mean þ S.E.M.
from ¢ve separate experiments.
Fig. 2. SNP induced apoptosis in HFF1 cells. HFF3 (A) and HFF1
(B) cells were treated as described in Fig. 1. The extent of apoptosis
was measured by PI staining and £ow cytometric analysis. (A) and
(B) show the temporal course of SNP-induced apoptosis. (C) SNP
induced apoptosis of HFF1 cells in a dose-dependent manner. The
level of apoptosis in HFF1 and HFF3 cells incubated with indicated
concentrations of SNP was determined 5 days after treatment. The
data are presented as mean þ S.E.M. from ¢ve separate experiments.
u
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100 WM (data not shown). All these ¢ndings advocate that
SNP brings about its e¡ects via NO.
3.4. Replenishment of G6PD changed biological responses
of HFF1 cells to NO from apoptosis to
growth stimulation
To test the possibility that G6PD per se was held respon-
sible for di¡erent biological responses of ¢broblasts to NO,
we investigated the e¡ect of ectopic expression of G6PD in
HFF1 cells. Cell lines stably carrying exogenous human G6PD
gene, LGIN and LKGIN, were generated by infection of
HFF1 cells with recombinant retroviral vector; LEIN cells,
which expressed EGFP, served as control [5]. Addition of
SNP caused a decrease in cell number of LEIN cells, while
it stimulated growth of LGIN and LKGIN cells (Fig. 4A). As
in the case of HFF1 cells, apoptosis accounted for the loss of
LEIN cells from SNP-treated cultures (Fig. 4B). It was clear
that expression of G6PD in LKGIN and LGIN cells pro-
tected them from NO-induced apoptosis.
3.5. cGMP pathway is not involved in transduction of growth
stimulatory and apoptotic signals of NO in HFF3 and
HFF1 cells
One of the ways by which NO elicits downstream biological
events is via activation of guanylate cyclase [10]. To examine
the potential role of the NO^guanylate cyclase signalling
pathway in transduction of growth stimulatory or apoptotic
signals in our ¢broblasts, two approaches were taken. First,
HFF1 and HFF3 were pre-treated with 10 WM of ODQ, the
inhibitor of guanylate cyclase, for 30 min before addition of
50 WM of SNP. As shown in Fig. 5A, ODQ did not a¡ect the
growth stimulatory e¡ect of NO donor on HFF3 cells. More-
over, it did not have any protective e¡ect on HFF1 cells
undergoing SNP-induced apoptosis (Fig. 5C,D). In the second
approach, a cell permeable cGMP analog, 8-bromo-cGMP,
was used to test whether it could mimic e¡ects of NO donor.
HFF1 and HFF3 cells were incubated with 1 mM of 8-bro-
mo-cGMP, 50 WM SNP, or both for 5 days. No signi¢cant
di¡erence in cell number between the cGMP analog-treated
HFF3 cells and untreated control was observed (Fig. 5A).
Nor did 8-bromo-cGMP a¡ect the extent of apoptosis in
HFF1 cells (or SNP-treated HFF1 cells) (Fig. 5C,D). These
data indicate that the cGMP pathway is not involved in the
action of NO donor on our human ¢broblasts.
3.6. NO-induced apoptosis, but not growth stimulation, involves
generation of oxidative stress
NO released from donor can form other reactive nitrogen
species (RNS), which can bring about oxidative or nitrosative
stress [11]. Recent study has shown that trolox can protect
leukemic cells from NO-induced apoptosis, implying the in-
volvement of oxidative stress [12]. To test the possibility that
RNS-evoked oxidative stress is involved in NO signalling in
our model system, we pre-incubated either HFF3 or HFF1
Fig. 4. Ectopic expression of G6PD changed the cellular response of HFF1 cells to SNP from apoptosis to stimulated proliferation. The HFF1
cells stably transduced with control retroviral vector (LEIN cells) or G6PD-expressing retroviruses (LGIN and LKGIN cells) were treated with
various concentrations of SNP for 5 days. The cell number determined is shown here (A). The percentage of apoptosis in LEIN, LGIN and
LKGIN cells was determined as described in Fig. 2 (B). The data are expressed as mean þ S.E.M. from ¢ve separate experiments.
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cells with trolox, and examined its e¡ect on the biological
outcomes of SNP treatment. As evident in Fig. 5A, trolox
did not change the growth stimulatory e¡ect of SNP on
HFF3 cells. The cell number did not vary signi¢cantly be-
tween the SNP-treated group (61.75 þ 2.63U105) and the tro-
lox- and SNP-treated group (58.54 þ 1.89U105). On the con-
trary, trolox treatment completely protected HFF1 cells from
SNP-induced apoptosis (Fig. 5C,D). However, such protec-
tion, unlike the e¡ect of ectopic G6PD expression, was not
associated with NO-induced growth stimulation. These ¢nd-
ings suggest that oxidative stress may be involved in NO-in-
duced apoptosis of HFF1 cells.
4. Discussion
In the present study, we show that G6PD is critical for
modulation of cellular responses to NO. SNP stimulated
growth of normal HFF3 cells (Fig. 1), whilst it caused apop-
tosis of G6PD-de¢cient HFF1 cells (Figs. 2 and 3). All these
e¡ects were nulli¢ed upon co-incubation with hemoglobin or
erythrocytes (data not shown). Additionally, potassium ferro-
cyanide or potassium ferricyanide, molecules structurally re-
lated to SNP but unable to generate NO, had no e¡ect on
HFF1 and HFF3 cells (data not shown). These ¢ndings in-
dicated that NO released from SNP was held responsible.
Replenishment of G6PD in HFF1 cells instigated them to
respond to NO by growth enhancement (Fig. 4), suggesting
that G6PD per se modulates the cellular responses to signal-
ling molecules. Moreover, our ¢ndings demonstrate that NO
did not e¡ect via the classical NO^cGMP pathway (Fig. 5).
The biological e¡ects of NO appear to be mediated by the
roles of NO or other RNS as oxidative and nitrosative agents.
Consistent with this, trolox, a potent antioxidant of lipid per-
oxidation, could protect the HFF1 cells from SNP-induced
apoptosis.
NO can exist in di¡erent chemical forms like NO, NO,
NO3, NO2, N2O3, ONOO3 and ONOOCO2. These RNS
have di¡erent chemical reactivities (i.e. oxidation, nitrosation,
nitration etc.) towards multifarious biological molecules, and
hence di¡erent e¡ects on cellular functions [11,13^15]. For
instance, S-nitrosylation of a critical cysteine residue of Ras
stimulates guanine nucleotide exchange and downstream sig-
nalling [16]. The exact identities, concentrations, half-lives and
reactivities of RNS in a cell, or more precisely in di¡erent
subcellular compartments, may depend on the local condition,
such as the redox status.
The ability of G6PD to alter the cellular responses to NO is
probably related to its indispensable role in production of
NADPH and sustenance of an adequate redox balance [17].
For example, G6PD-null mutants of Saccharomyces cerevisiae
and murine embryonic stem cells are extremely sensitive to
oxidizing agents [7,18]. In addition, our G6PD-de¢cient
HFF1 cells have an NADPH/NADP ratio reduced by
50%, as compared with HFF3 cells (unpublished observation).
Fig. 5. Guanylate^cGMP pathway did not mediate the e¡ects of SNP on HFF1 and HFF3 cells. HFF1 and HFF3 cells were pre-incubated
with 10 WM of ODQ or 1 mM 8-bromo-cGMP for 30 min before treatment with (or without) 50 WM of SNP. For treatment with trolox,
HFF1 and HFF3 cells were pre-incubated with 200 WM of trolox prior to SNP addition (or without SNP treatment). Cell number (A and C)
and level of apoptosis (B and D) of HFF3 (A and B) and HFF1 (C and D) were determined 5 days after drug treatment. Results are expressed
as mean þ S.E.M. from ¢ve separate experiments.
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Apparently, G6PD de¢ciency changes the intracellular milieu
to a more oxidizing environment.
Redox homeostasis is critical to numerous physiological
processes, and modulates cell growth and survival signals
[19,20^23]. A shift in redox balance towards formation of
more reactive oxygen species in G6PD-de¢cient cells causes
alteration in cell physiology [5,24]. In the current study, we
demonstrate that G6PD status determines the cellular re-
sponses to NO. It is probable that the regulatory molecules,
such as signal transducers, or the e¡ector molecules within
growth or apoptotic pathways are targets of redox control.
Changes in redox states of these molecules, such as reversible
oxidation of -SH groups of cysteine residues, may modulate
their biological activities as well as their reactivities towards
RNS [15,25]. For example, the cysteine residues of N-methyl-
D-aspartate receptor react with NO only if they are in the
free sulfhydryl state [15]. Hence, depending on the redox sta-
tus, these regulators or e¡ectors may determine the cellular
responses to NO: a reducing cellular environment in HFF3
cells favors proliferation, whereas a more oxidizing environ-
ment predisposes HFF1 cells to apoptosis. Consistent with
this, ectopic expression of G6PD in HFF1 cells prevented
apoptosis and restored the growth response to NO. Addition-
ally, trolox protected G6PD-de¢cient cells from SNP-induced
apoptosis, suggesting RNS-evoked oxidative stress and lipid
peroxidation as critical events in NO-induced apoptosis. Per-
oxidation of mitochondrial lipids, in particular cardiolipin,
has been shown to play a crucial role in apoptosis [12]. Inter-
estingly, there was a lack of e¡ect of trolox on SNP-stimu-
lated growth of HFF3 cells. Two plausible explanations exist.
First, NO or RNS may still stimulate proliferation of HFF3
cells via oxidant signalling, but lipid peroxidation is not in-
volved in mitogenic signalling. Second, di¡erent activities of
RNS, such as nitration of tyrosine residue, may be involved in
regulation of the growth signalling pathway. Experiments are
under way to test these possibilities. Taken together, the
present study demonstrates that G6PD plays an important
role in proper functioning of the cell’s growth and survival
machinery.
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